Adicet Bio(ACET)
$2.99-0.01 (-0.33%)
ACET
Adicet Bio financials statements
$2.99
At close:-0.01 (-0.33%)
Want to see ACET full AI Analyst Report?
Adicet Bio (ACET) Ratios
948 Followers
Adicet Bio Ratios
ACET's free cash flow for Q3 2026 was $-17.98M. For the 2026 fiscal year, ACET's free cash flow was decreased by $-56.00K and operating cash flow was $-17.92M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.47 | 9.29 | 8.41 | 13.25 | 17.31 |
| Quick Ratio | 7.47 | 9.29 | 8.41 | 13.25 | 17.31 |
| Cash Ratio | 1.81 | 2.91 | 8.28 | 13.07 | 17.01 |
| Solvency Ratio | -3.33 | -3.29 | -3.68 | -1.69 | -1.69 |
| Operating Cash Flow Ratio | -4.42 | -4.76 | -4.86 | -2.27 | -3.13 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 127.78M | $ 146.53M | $ 125.15M | $ 222.69M | $ 246.63M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.08 | 0.10 | 0.06 | 0.06 |
| Debt-to-Equity Ratio | 0.09 | 0.09 | 0.12 | 0.07 | 0.07 |
| Debt-to-Capital Ratio | 0.08 | 0.08 | 0.11 | 0.07 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.21 | 1.18 | 1.22 | 1.13 | 1.12 |
| Debt Service Coverage Ratio | -3066.28 | -27662.50 | 0.00 | -808.76 | -342.53 |
| Interest Coverage Ratio | -3392.06 | -31903.75 | 0.00 | -906.89 | -349.05 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.14 | 3.14 | 7.78 | 8.22 | 10.92 |
| Net Debt to EBITDA | 0.22 | 0.35 | 1.02 | 3.66 | 4.25 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | -278.95% | -636.67% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | -258.91% | -620.86% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | -290.32% | -631.38% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | -279.27% | -638.48% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | -279.27% | -637.19% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | -279.27% | -637.19% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 99.80% |
| EBT Per EBIT | 95.65% | 91.78% | 93.83% | 96.19% | 101.12% |
| Return on Assets (ROA) | -60.72% | -53.18% | -68.82% | -21.10% | -18.29% |
| Return on Equity (ROE) | -73.36% | -62.76% | -83.83% | -23.87% | -20.45% |
| Return on Capital Employed (ROCE) | -71.49% | -63.54% | -80.87% | -23.33% | -19.04% |
| Return on Invested Capital (ROIC) | -70.18% | -62.57% | -79.51% | -23.14% | -18.91% |
| Return on Tangible Assets | -60.72% | -53.18% | -68.82% | -22.42% | -19.41% |
| Earnings Yield | -201.30% | -138.58% | -175.36% | -19.00% | -11.45% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 57.45 | 45.47 |
| Payables Turnover | 1.35 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.51 | 0.28 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.08 | 0.03 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.10 | 0.06 |
| Cash Conversion Cycle | -271.08 | 0.00 | 0.00 | 6.35 | 8.03 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 6.35 | 8.03 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 271.08 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 6.35 | 8.03 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -13.82 | -16.82 | -34.84 | -17.44 | -26.39 |
| Free Cash Flow Per Share | -14.07 | -17.03 | -36.50 | -23.97 | -33.13 |
| Dividend Paid and CapEx Coverage Ratio | -54.80 | -82.63 | -20.99 | -2.67 | -3.91 |
| Capital Expenditure Coverage Ratio | -54.80 | -82.63 | -20.99 | -2.67 | -3.91 |
| Operating Cash Flow Coverage Ratio | -6.46 | -5.36 | -4.48 | -2.13 | -2.44 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | -1.79 | -5.25 |
| Free Cash Flow Yield | -167.14% | -110.62% | -120.69% | -16.76% | -11.84% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.50 | -0.72 | -0.57 | -5.26 | -8.73 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 14.70 | 55.64 |
| Price-to-Book (P/B) Ratio | 0.36 | 0.45 | 0.48 | 1.26 | 1.79 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.60 | -0.90 | -0.83 | -5.97 | -8.45 |
| Price-to-Operating Cash Flow Ratio | -0.61 | -0.91 | -0.87 | -8.20 | -10.60 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.01 | -0.01 | 0.35 | 0.15 |
| Enterprise Value Multiple | -0.31 | -0.41 | 0.42 | -2.02 | -4.71 |
| Enterprise Value | 33.85M | 45.26M | -57.44M | 130.62M | 284.75M |
| EV to EBITDA | -0.31 | -0.41 | 0.42 | -2.02 | -4.71 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 5.23 | 29.27 |
| EV to Free Cash Flow | -0.35 | -0.48 | 0.59 | -2.12 | -4.44 |
| EV to Operating Cash Flow | -0.36 | -0.49 | 0.61 | -2.92 | -5.58 |
| Tangible Book Value Per Share | 23.10 | 33.98 | 63.26 | 106.28 | 146.64 |
| Shareholders’ Equity Per Share | 23.10 | 33.98 | 63.26 | 113.86 | 156.70 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 9.73 | 5.03 |
| Net Income Per Share | -16.95 | -21.33 | -53.03 | -27.18 | -32.05 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 2.85 | 5.03 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 1.05 | 2.28 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.69 | 1.29 |
| Income Quality | 0.82 | 0.79 | 0.66 | 0.64 | 0.82 |
Currency in USD
